Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment
J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …
Mechanisms of chemotherapy-induced peripheral neuropathy
R Zajączkowska, M Kocot-Kępska, W Leppert… - International journal of …, 2019 - mdpi.com
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …
effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically …
Calcium signaling regulates autophagy and apoptosis
Calcium (Ca2+) functions as a second messenger that is critical in regulating fundamental
physiological functions such as cell growth/development, cell survival, neuronal …
physiological functions such as cell growth/development, cell survival, neuronal …
Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
Cytotoxic chemotherapy is an effective treatment for invasive breast cancer. However,
experimental studies in mice also suggest that chemotherapy has pro-metastatic effects …
experimental studies in mice also suggest that chemotherapy has pro-metastatic effects …
Pathophysiology of chemotherapy-induced peripheral neuropathy
H Starobova, I Vetter - Frontiers in molecular neuroscience, 2017 - frontiersin.org
Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several
antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment …
antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment …
Paclitaxel's mechanistic and clinical effects on breast cancer
TM Abu Samaan, M Samec, A Liskova, P Kubatka… - Biomolecules, 2019 - mdpi.com
Paclitaxel (PTX), the most widely used anticancer drug, is applied for the treatment of
various types of malignant diseases. Mechanisms of PTX action represent several ways in …
various types of malignant diseases. Mechanisms of PTX action represent several ways in …
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
VA Carozzi, A Canta, A Chiorazzi - Neuroscience letters, 2015 - Elsevier
Cisplatin, oxaliplatin, paclitaxel, vincristine and bortezomib are some of the most effective
drugs successfully employed (alone or in combinations) as first-line treatment for common …
drugs successfully employed (alone or in combinations) as first-line treatment for common …
Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids
YJ Li, JF Fahrmann, M Aftabizadeh, Q Zhao… - Cell reports, 2022 - cell.com
Overcoming resistance to chemotherapies remains a major unmet need for cancers, such as
triple-negative breast cancer (TNBC). Therefore, mechanistic studies to provide insight for …
triple-negative breast cancer (TNBC). Therefore, mechanistic studies to provide insight for …
Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems
NP Staff, JC Fehrenbacher, M Caillaud, MI Damaj… - Experimental …, 2020 - Elsevier
Abstract Paclitaxel (Brand name Taxol) is widely used in the treatment of common cancers
like breast, ovarian and lung cancer. Although highly effective in blocking tumor progression …
like breast, ovarian and lung cancer. Although highly effective in blocking tumor progression …
Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy
To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier
into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance …
into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance …